Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
| Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
MBRpFkydWWmRHdbU
Listen
